Results 181 to 190 of about 6,585,193 (310)

Correction: Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology. [PDF]

Br J Cancer
Gori S, Venturelli F, Carozzi F, Giorgi Rossi P, Del Mistro A, Multisocietal Contributor Group.   +5 more
europepmc   +1 more source

Feasibility of a Risk-Based Approach to Cataract Surgery Preoperative Medical Evaluation.

JAMA Ophthalmol, 2021
Cuttitta A, Joseph SS, Henderson J, Portney DS, Keedy JM, Benedict WL, Lahti H, Klarr PS, Shtein RM, Lee PP, Kerr E, Mian SI.   +11 more
europepmc   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

Molecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel, Izabela Kubiak, Lena Rutkowska, Żaneta Kasprzyk, Łukasz Kępczyński, Michał Bednarek, Dariusz Sobieraj, Jacek Wilkosz, Piotr Kania, Adam Jędrzejczyk, Bogdan Kałużewski, Agnieszka Gach, Tadeusz Kałużewski   +12 more
wiley   +1 more source

Reply to "Reevaluating thromboprophylaxis in COVID-19 outpatients: the case for a targeted, risk-based approach". [PDF]

Res Pract Thromb Haemost
Di Vece D, Connors JM, Barco S.
europepmc   +1 more source

Evaluation of Data Errors and Monitoring Activities in a Trial in Japan Using a Risk-Based Approach Including Central Monitoring and Site Risk Assessment. [PDF]

Ther Innov Regul Sci, 2021
Kondo H, Kamiyoshihara T, Fujisawa K, Nojima T, Tanigawa R, Fujiwara H, Suganami H, Hayashi Y, Yamaguchi T.   +8 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Reevaluating thromboprophylaxis in COVID-19 outpatients: the case for a targeted, risk-based approach. [PDF]

Res Pract Thromb Haemost
Kow CS, Ramachandram DS, Hasan SS, Thiruchelvam K.   +3 more
europepmc   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source

Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology. [PDF]

Br J Cancer
Gori S, Venturelli F, Carozzi F, Giorgi Rossi P, Del Mistro A, Multisocietal Contributor Group.   +5 more
europepmc   +1 more source

Comparison of safety factor approach and the risk-based approach

, 2012
Master's thesis in Offshore ...
openaire   +1 more source